PUMA BIOTECHNOLOGY, INC. Lessor, Operating Lease, Payment to be Received, Year Five
PUMA BIOTECHNOLOGY, INC. (PBYI) had Lessor, Operating Lease, Payment to be Received, Year Five of $133.00 thousand as of 2021-12-31, per its 10-K filed 2022-03-03.
Discontinued › Notes › Leases › Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity
us-gaap:LessorOperatingLeasePaymentsToBeReceivedFiveYears · last filed 2022-03-03
- 2021-12-31: Lessor, Operating Lease, Payment to be Received, Year Five $133.00K.
- 2020-12-31: Lessor, Operating Lease, Payment to be Received, Year Five $525.00K.
- 2020-03-31: Lessor, Operating Lease, Payment to be Received, Year Five $510.00K.
- 2019-12-31: Lessor, Operating Lease, Payment to be Received, Year Five $510.00K.
| Period end | Lessor, Operating Lease, Payment to be Received, Year Five |
|---|---|
| 2021-12-31 | $133.00K 10-K · filed 2022-03-03 |
| 2020-12-31 | $525.00K 10-K · filed 2021-03-01 |
| 2020-03-31 | $510.00K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $510.00K 10-K · filed 2020-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |